Congratulations to our current PGY2, Erin, on the publication of her PGY1 research evaluating cephalexin dosing for uncomplicated SSTI in @OFIDJournal! Definitely on Team 1g TID dosing of cephalexin! @DrJaymoGR@KmEid_
https://t.co/ZDiijiez0x
Listen into Episode 143 "Tiny Lungs, Big Protection: RSV Prevention in Infants” paired with an infographic to keep the key points at your fingertips.
PDF version available via our website: https://t.co/KzCLpey1Uh
#infographic#rsvseason
📢 Calling all program directors! Have a great program to highlight? Use the link (also in today's email) to submit info about your program to be featured during recruitment szn and leading up to Antimicrobials 2027 - 🔗 https://t.co/9CRIK6QV01
Survey closes October 30th!
Get excited for the Antimicrobials Conference coming to Baltimore, MD from May 22-26, 2027! Can't wait to see you all there 🤗 #SIDPharm#MADID#Antimicrobials2027
Only TWO DAYS until the next webinar on landmark trials in #InfectiousDiseases - this session will be surrounding the advancing role of oral therapy💊
📆September 30th
⏰11am CST/12pm EST
🔗 https://t.co/AaVA358CNl
Think you know HSV? Take a closer look 🔍 This infographic reviews the management of resistant and refractory HSV! Developed by SIDP member, Nikki Tran, sponsored by AiCuris US, Inc.
Don't miss out! Catch up on more landmark trials in #InfectiousDiseases this time surrounding the advancing role of oral therapy💊
📆September 30th
⏰11am CST/12pm EST
🔗 https://t.co/AaVA358CNl
📣 Calling all ID learners! Share the podcast with your co-residents and co-fellows or anyone looking to gain more ID knowledge. Join the conversation. Tell us what ID topics you would like to be discussed on future podcast episodes. 🦠
https://t.co/KzCLpexu4J
What’s driving antifungal drug resistance, and what does it mean for clinical care?
Join CDC + SIDP for a special #FungalDiseaseAwarenessWeek webinar featuring antifungal expert Jeffrey M. Rybak, PharmD, PhD.
Sept. 15: 1 p.m. ET (12 p.m. CT)
Register: https://t.co/QVoxnnWpgp
Promotion, publication, award, or innovative practice? SIDP would like to highlight your achievements in the upcoming newsletter! Please take 2 minutes to highlight your work in this form: https://t.co/tdqSpE6lTf. Bookmark it to submit your accomplishments year-round.
This infographic is a fantastic summary of the beta-lactamase inhibitors reviewed in the new #Breakpoints episode "Beta-lactamase inhibitors: Scientifically elegant, just complex." Use this infographic as a reference, and be sure to share!
#infographic#newepisode
Spread the news! Submissions for SIDP's Educational Grant Program are open 📚 Do you have a project that advances ID pharmacy and antimicrobial stewardship? SIDP wants to support you - go to https://t.co/MVQFScFExT to download the proposal application and get started!
Next stop: San Diego! 🌞🌴 Mark your calendars 📅 for Antimicrobials 2028 (May 3–6) and get ready for learning, collaboration, and connection with the infectious diseases community. ✨ #MADID#SIDPharm#Antimicrobials2028
Headed home with a full heart & no shortage of new ideas from #MADIDxSIDP2026! And so proud of our THGR residents who presented their research. Excited & energized to start planning the 2027 Antimicrobials meeting & kick off the new operating year for @SIDPharm! @MAD_ID_ASP
Worth the early wake up to learn about Metallo-beta-lactamases from our experts at #MADIDxSIDP this morning! The ever-changing landscape in MDRO GNR diagnosis & treatment showing us why this is such a hot topic needing frequent updates @MAD_ID_ASP@SIDPharm